Product image of Metronidazole B. Braun Melsungen (Metronidazole) supplied by GNH India

Metronidazole B. Braun Melsungen

Active Ingredient:
Metronidazole
Origin:
EU

Metronidazole B. Braun Melsungen (Metronidazole)

Metronidazole, the active ingredient in Metronidazole B. Braun Melsungen, is a nitroimidazole presented as a sterile powder for reconstitution for intravenous injection use. It is indicated for the treatment of anaerobic bacterial infections, bacterial vaginosis, trichomoniasis, amebic liver abscess, and Clostridioides difficile infection in adult patients.

GNH India supplies Metronidazole B. Braun Melsungen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide, providing reliable sourcing and regulatory support for global healthcare providers.

Manufacturer / TM Owner

B.Braun Melsungen Ag

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metronidazole is a nitroimidazole antibiotic used to treat infections caused by anaerobic bacteria and certain protozoa.

  • Anaerobic bacterial infections: effective in eradicating mixed anaerobic infections in intra‑abdominal, pelvic, and skin‑soft tissue sites.
  • Bacterial vaginosis: restores normal vaginal flora by eliminating Gardnerella and other anaerobes.
  • Trichomoniasis: eliminates Trichomonas vaginalis infection in women.
  • Amebic liver abscess: treats Entamoeba histolytica hepatic infection.
  • Clostridioides difficile infection: used as part of therapy for severe C. difficile colitis.

How It Works

  • Metronidazole is taken up by anaerobic microorganisms and reduced by ferredoxin‑type proteins to generate nitro radical anions. These reactive metabolites bind to DNA, causing strand breakage and inhibiting nucleic acid synthesis, which leads to bacterial and protozoal cell death while sparing aerobic cells.

Side Effects

Metronidazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Nausea: mild gastrointestinal upset.
  • Metallic taste: transient dysgeusia.
  • Headache: mild to moderate intensity.
  • Diarrhea: loose stools.
  • Abdominal pain: crampy discomfort.
  • Rash: mild skin erythema.

Serious or Rare Side Effects

  • Seizures: neurologic events.
  • Peripheral neuropathy: tingling or numbness.
  • Stevens‑Johnson syndrome: severe skin reaction.
  • Hepatotoxicity: elevated liver enzymes.
  • Anaphylaxis: acute allergic response.
  • Methemoglobinemia: reduced oxygen carrying capacity.

Precautions & Warnings

Before using Metronidazole, consider the following precautions to ensure safe and effective therapy.

  • Renal impairment: adjust dosing in severe renal dysfunction.
  • Hepatic disease: monitor liver function tests.
  • Alcohol consumption: avoid alcohol due to disulfiram‑like reaction.
  • Pregnancy: use only if clearly needed; risk unknown.
  • Lactation: discontinue nursing or stop drug as it may be excreted in milk.
  • Concomitant neurotoxic drugs: monitor for additive neuropathy.
  • Store at ambient temperature: keep below 25°C, protect from moisture and light in original container.

Avoid Interactions

Metronidazole can interact with several medicines, altering efficacy or increasing toxicity.

Major Interactions (Avoid)

  • Alcohol: causes severe flushing, tachycardia, and nausea.
  • Warfarin: may enhance anticoagulant effect, increasing bleeding risk.
  • Lithium: can raise lithium levels, leading to toxicity.

Moderate Interactions (Monitor Closely)

  • Phenytoin: may reduce metronidazole levels.
  • Cimetidine: may increase metronidazole plasma concentration.
  • Carbamazepine: may decrease metronidazole effectiveness.
  • Phenobarbital: may lower metronidazole concentrations.

Frequently Asked Questions

Metronidazole B. Braun Melsungen is an intravenous nitroimidazole antibiotic indicated for the treatment of anaerobic bacterial infections, bacterial vaginosis, trichomoniasis, amebic liver abscess, and severe Clostridioides difficile infection in adult patients.

Metronidazole enters anaerobic microorganisms and is reduced to nitro radical anions. These reactive metabolites bind to DNA, causing strand breakage and inhibiting nucleic acid synthesis, which results in bacterial and protozoal cell death while sparing aerobic cells.

The dosing regimen for Metronidazole B. Braun Melsungen is determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and local treatment guidelines.

Safety data for Metronidazole in pregnancy are limited; it should be used only when clearly needed and after risk‑benefit assessment. The drug is excreted in breast milk, so nursing mothers should either discontinue breastfeeding or stop the medication.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and import documentation.

Metronidazole is the most widely used nitroimidazole, offering a broad spectrum against anaerobes and certain protozoa. Alternatives such as tinidazole have a longer half‑life and may require less frequent dosing, but Metronidazole remains the first‑line choice for many indications due to extensive clinical experience and established guidelines.

The product should be stored at ambient temperature, preferably below 25 °C, protected from moisture and light. Keep the vial in its original packaging until use and reconstitute with the recommended diluent under aseptic conditions before intravenous administration.

Metronidazole B. Braun Melsungen is supplied as a sterile powder for injection. It must be reconstituted with a compatible diluent, filtered if required, and administered intravenously over the period specified by the prescriber, typically as a slow infusion.

Serious adverse events include seizures, peripheral neuropathy, Stevens‑Johnson syndrome, hepatotoxicity, anaphylaxis, and methemoglobinemia. Patients should be monitored for neurological symptoms, skin reactions, and liver function abnormalities during therapy.

Metronidazole is contraindicated in patients with a known hypersensitivity to the drug or other nitroimidazoles. Caution is advised in individuals with severe hepatic impairment, those receiving disulfiram, and patients with a history of severe neurological reactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.